Recent advances in molecular pathobiology of gastric carcinoma

The Diversity of Gastric Carcinoma: Pathogenesis, Diagnosis, and Therapy

Volumn , Issue , 2005, Pages 51-71

  Yasui, Wataru ^a   Oue, Naohide ^a   Kitadai, Yasuhiko ^a   Nakayama, Hirofumi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645309177     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/4-431-27713-7_3     Document Type: Chapter

References (62)

1. Tahara E (1993) Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 119:265-272
2. Yasui W, Oue N, Kuniyasu H, et al (2001) Molecular diagnosis of gastric cancer: present and future. Gastric Cancer 4:113-121
3. Ohgaki H, Yasui W, Yokota J (2003) Genetic pathway to human cancer. In: Vainio H, Hietanen E (eds) Handbook of experimental pharmacology. Mechanisms in carcinogenesis and cancer research. Springer, Heidelberg, pp 25-39
4. Yokozaki H, Yasui W, Tahara E (2001) Genetic and epigenetic changes in stomach cancer. Int Rev Cytol 204:49-95
5. Yasui W, Oue N, Ono S, et al (2003) Histone acetylation and gastrointestinal carcinogenesis. Ann NY Acad Sci 983:220-231
6. Todaro GJ, Huebner RJ (1972) N.A.S. symposium: new evidence as the basis for increased efforts in cancer research. Proc Natl Acad Sci USA 69:1009-1015
7. Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823
8. Nakasato F, Sakamoto H, Mori M, et al (1984) Amplification of the c-myc oncogene in human stomach cancers. Gann (Jpn J Cancer Res) 75:737-742
9. Sakamoto H, Mori M, Taira M, et al (1986) Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc Natl Acad Sci USA 83:3997-4001
10. Yasui W, Yokozaki H, Shimamoto F, et al (1999) Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology Pathol Int 49:763-774
11. Kim NW, Piatyszek MA, Prowse KR, et al (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015
12. Yasui W, Tahara E, Tahara E, et al (1999) Immunohistochemical detection of human telom-eraase reverse transcriptase in normal and precancerous lesions of the stomach. Jpn J Cancer Res 90:589-595
13. Kondo T, Oue N, Mitani Y, et al (2005) Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. Oncogene 24:157-164
14. Kondo T, Oue N, Yoshida K, et al (2004) Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 64:523-529
15. Fleisher AS, Esteller M, Wang S, et al (1999) Hypermethylation of the hMLHl promoter in human gastric cancers with microsatellite instability. Cancer Res 59:1090-1095
16. Takahashi Y, Cleary KR, Mai M, et al (1996) Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 2:1679-1684
17. Kitadai Y, Haruma K, Sumii K, et al (1998) Expression of IL-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 152:93-100
18. Takahashi Y, Bucana CD, Akagi Y, et al (1998) Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clin Cancer Res 4:429-434
19. Kitadai Y, Takahashi Y, Haruma K, et al (1999) Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer 81: 647-653
20. Kitadai Y, Haruma K, Mukaida N, et al (2000) Regulation of disease-progression genes in human gastric carcinoma cells by interleukin-8. Clin. Cancer Res 6:2735-2740
21. Kitadai Y, Sasaki A, Ito M, et al (2003) Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochem Biophys Res Commun 311:809-814
22. Tatematsu M, Tsukamoto T, Inada K (2003) Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 94:135-141
23. Ohmura K, Tamura G, Endoh Y, et al (2000) Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype. Hum Pathol 31:1031-1035
24. Yokozaki H, Shitara Y, Fujimoto J, et al (1999) Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype. Int J Cancer 83:192-196
25. Almeida R, Silva E, Santos-Silva F, et al (2003) Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol 199:36-40
26. Yamamoto H, Bai YQ, Yuasa Y (2003) Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem Biophys Res Commun 300:813-818
27. Grotzinger C, Kneifel J, Patschan D, et al (2001) LI-cadherin: a marker of gastric metaplasia and neoplasia. Gut 49:73-81
28. Hippo Y, Taniguchi H, Tsutsumi S, et al (2002) Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 62:233-240
29. Yasui W, Oue N, Ito R, et al (2004) Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 95:385-392
30. Hinoi T, Lucas PC, Kuick R, et al (2002) CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 123: 1565-1577
31. Oshimo Y, Oue N, Mitani Y, et al (2004) Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Pathobiology 71:137-143
32. Oue N, Shigeishi H, Kuniyasu H, et al (2001) Promoter methylation of MGMT is associated with protein loss in gastric carcinomas. Int J Cancer 93:805-809
33. Oue N, Matsumura S, Nakayama H, et al (2003) Expression of theTSP-1 gene and its association with promoter hypermethylation in gastric carcinomas. Oncology 64:423-429
34. Hamai Y, Oue N, Mitani Y, et al (2003) DNA methylation and histone acetylation status of HLTF gene are associated with reduced expression in gastric carcinoma. Cancer Sci 94:692-698
35. Oshimo Y, Oue N, Mitani Y, et al (2004) Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma. Int J Cancer 110:212-218
36. Satoh A, Toyota M, Itoh F, et al (2003) Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. Cancer Res 63:8606-8613
37. Toyota M, Ahuja N, Suzuki H, et al (1999) Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59:5438-5442
38. Kaneda A, Kaminishi M, Yanagihara K, et al (2002) Identification of silencing of nine genes in human gastric cancers. Cancer Res 62:6645-6650
39. Oue N, Motoshita J, Yokozaki H, et al (2002) Distinct promoter hypermethylation of p16ink4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinoma. J Pathol 198:55-59
40. Oue N, Oshimo Y, Mitani Y, et al (2003) DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci 94:901-905
41. Kang GH, Shim Y-H, Jung H-Y, et al (2001) CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 61:2847-2851
42. Rhee I, Bachman KE, Park BH, et al (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature (Lond) 416:552-556
43. Robert M-F, Morin S, Beaulieu N, et al (2003) DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 33:61-65
44. Kouzarides T (1999) Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 9:40-48
45. Kouzarides T (2002) Histone methylation in transcriptional control. Curr Opin Genet Dev 12:198-209
46. Gonzalez CA, Sala N, Capella G (2002) Genetic susceptibility and gastric cancer risk. Int J Cancer 100:249-260
47. Wu M-S, Huang S-P, Chang Y-T, et al (2002) Association of the-160 C Æ A promoter polymorphism of the E-cadherin gene with gastric carcinoma risk. Cancer (Phila) 94:1443-1448
48. Pharoah PDP, Oliveira C, Machado JC, et al (2002) CDH1 c-160a promoter polymorphism is not associated with risk of stomach cancer. Int J Cancer 101:196-197
49. Watters JW, McLeod HL (2003) Cancer pharmacogenomics: current and future applications. Biochim Biophys Acta 1603:99-111
50. El-Rifai W, Frierson HF Jr, Harper JC, et al (2001) Expression profiling of gastric adenocarcinoma using cDNA array. Int J Cancer 92:832-838
51. Hasegawa S, Furukawa Y, Li M, et al (2002) Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23 040 genes. Cancer Res 62:7012-7017
52. Inoue H, Matsuyama A, Mimori K, et al (2002) Prognostic score of gastric cancer determined by cDNA microarray. Clin Cancer Res 8:3475-3479
53. Zembutsu H, Ohnishi Y, Tsunoda T, et al (2002) Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. Cancer Res 62:518-527
54. Velculescu VE, Zhang L, Vogelstein B, et al (1995) Serial analysis of gene expression. Science 270:484-487
55. El-Rafai W, Moskaluk CA, Abdrabbo MK, et al (2002) Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 62:6823-6826
56. Oien KA, Vass JK, Downie I, et al (2003) Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach. Oncogene 22:4287-4300
57. Lee J-Y, Eom E-M, Kim D-S, et al (2003) Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE. Genomics 82:78-85
58. Oue N, Hamai Y, Mitani Y, et al (2004) Gene expression profile of gastric carcinoma; identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 64:2397-2405
59. Hicks GG, Singh N, Nashabi A, et al (2000) Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet 24:175-179
60. Hartupee JC, Zhang H, Bonaldo MF, et al (2001) Isolation and characterization of a cDNA encoding a novel member of the human generating protein family. Biochim Biophys Acta 1518:287-293
61. Zhang X, Huang Q, Yang Z, et al (2004) GW112, a novel antiapoptotic protein that promotes tumor growth. Cancer Res 64:2474-2481
62. Krupnik VE, Sharp JD, Jiang C, et al (1999) Functional and structural diversity of the human Dickkopf gene family. Gene (Amst) 238:301-313